What is the average price target for ZIONS BANCORP NA (ZION) stock?
29 analysts have analysed ZION and the average price target is 68.07 USD. This implies a price increase of 28.19% is expected in the next year compared to the current price of 53.1.
NASDAQ:ZION • US9897011071
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ZIONS BANCORP NA (ZION).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-09 | Baird | Upgrade | Neutral -> Outperform |
| 2026-03-02 | Morgan Stanley | Upgrade | Equal-Weight -> Overweight |
| 2026-02-05 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2026-01-23 | Citigroup | Maintains | Neutral -> Neutral |
| 2026-01-22 | Truist Securities | Maintains | Hold -> Hold |
| 2026-01-21 | TD Cowen | Maintains | Hold -> Hold |
| 2026-01-21 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2026-01-21 | Stephens & Co. | Maintains | Equal-Weight -> Equal-Weight |
| 2026-01-21 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2026-01-07 | TD Cowen | Maintains | Hold -> Hold |
| 2026-01-06 | Evercore ISI Group | Downgrade | Outperform -> In-Line |
| 2026-01-05 | Barclays | Maintains | Underweight -> Underweight |
| 2025-12-16 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-12-15 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-11-19 | Jefferies | Upgrade | Hold -> Buy |
| 2025-11-05 | UBS | Maintains | Neutral -> Neutral |
| 2025-10-23 | B of A Securities | Upgrade | Underperform -> Neutral |
| 2025-10-21 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-10-17 | Baird | Upgrade | Neutral -> Outperform |
| 2025-10-16 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-09-30 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-09-29 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-09-25 | TD Cowen | Initiate | Hold |
| 2025-09-10 | Cantor Fitzgerald | Initiate | Overweight |
| 2025-07-23 | Truist Securities | Maintains | Hold -> Hold |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 3.115B -1.17% | 3.13B 0.48% | 3.385B 8.15% | 3.594B 6.17% | 3.762B 4.67% | 3.869B 2.84% | 3.862B -0.18% | 3.994B 3.42% | 4.13B 3.41% | 4.271B 3.41% | 4.417B 3.42% | |
| EBITDA YoY % growth | N/A | N/A | N/A | 1.032B | N/A | 1.434B | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | N/A -9.92% | N/A -6.50% | N/A 16.42% | 1.341B 6.85% | 1.399B 4.33% | 1.404B 0.36% | 1.432B 1.99% | 1.494B 4.33% | 1.558B 4.28% | 1.625B 4.30% | 1.695B 4.31% | |
| Operating Margin | N/A | N/A | N/A | 37.31% | 37.19% | 36.29% | 37.08% | 37.41% | 37.72% | 38.05% | 38.37% | |
| EPS YoY % growth | 4.86 -16.21% | 4.96 2.06% | 6.00 20.97% | 6.33 5.46% | 6.67 5.47% | 7.09 6.18% | 6.62 -6.58% | 7.07 6.78% | 7.54 6.64% | 8.04 6.63% | 8.27 2.92% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.44 27.61% | 1.57 -3.59% | 1.62 9.31% | 1.63 -7.49% | 1.43 -0.88% | 1.57 0.13% | 1.67 3.44% | 1.70 4.19% |
| Revenue Q2Q % growth | 869.9M 9.42% | 890.27M 6.24% | 905.89M 5.21% | 917.83M 3.01% | 901.27M 3.61% | 920.65M 3.41% | 939.37M 3.70% | 957.63M 4.34% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 302.66M 11.20% | 327.91M 13.22% | 343.3M 8.63% | 350.72M 4.64% | 312.73M 3.33% | 343.84M 4.86% | 357.71M 4.20% | 371.89M 6.04% |
All data in USD
29 analysts have analysed ZION and the average price target is 68.07 USD. This implies a price increase of 28.19% is expected in the next year compared to the current price of 53.1.
ZIONS BANCORP NA (ZION) will report earnings on 2026-04-20.
The consensus EPS estimate for the next earnings of ZIONS BANCORP NA (ZION) is 1.44 USD and the consensus revenue estimate is 869.90M USD.
The consensus rating for ZIONS BANCORP NA (ZION) is 71.0345 / 100 . This indicates that analysts generally have a positive outlook on the stock.